Latest Breaking News On - Go annual meeting on womens cancer - Page 1 : comparemela.com

Oliver Dorigo, MD, PhD, discusses the investigation of CRX100 in patients with recurrent, platinum-resistant ovarian cancer.

United statesOliver dorigoMary lake polan gynecologic oncology research laboratoryDivision of gynecologic oncologyStanford gynecologic oncology clinical care programStanford gynecologic oncology fellowshipStanford clinical research groupGynecologic cancer trialsStanford obstetricsGynecologic oncologyRecurrent ovarian cancerGo annual meeting on womens cancerPlatinum resistant